Related references
Note: Only part of the references are listed.Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality - A prospective population-based study in 76 113 Austrian adults
Alexander M. Strasak et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Should liver function tests be included in definitions of metabolic syndrome? Evidence from the association between liver function tests, components of metabolic syndrome and prevalent cardiovascular disease
M. C. Devers et al.
DIABETIC MEDICINE (2008)
γ-Glutamyltransferase predicts cardiovascular death among Japanese women
Atsushi Hozawa et al.
ATHEROSCLEROSIS (2007)
Alanine aminotransferase predicts coronary heart disease events: A 10-year follow-up of the Hoorn Study
Roger K. Schindhelm et al.
ATHEROSCLEROSIS (2007)
Non-alcoholic fatty liver disease and increased risk of cardiovascular disease
Giovanni Targher et al.
ATHEROSCLEROSIS (2007)
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk - The Framingham Heart Study
Douglas S. Lee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Serum γ-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population
C. Meisinger et al.
ATHEROSCLEROSIS (2006)
Change of serum albumin and risk of cardiovascular disease and all-cause mortality
B. W. M. Schalk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
A second-generation genetic linkage map of the baboon (Papio hamadryas) genome
Laura A. Cox et al.
GENOMICS (2006)
Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients
G Targher et al.
DIABETES (2005)
γ-glutamyltransferase as a risk factor for cardiovascular disease mortality -: An epidemiological investigation in a cohort of 163,944 Austrian adults
E Ruttmann et al.
CIRCULATION (2005)
Genome-wide scan of resistin mRNA expression in omental adipose tissue of baboons
ME Tejero et al.
INTERNATIONAL JOURNAL OF OBESITY (2005)
Recent concepts in non-alcoholic fatty liver disease
LA Adams et al.
DIABETIC MEDICINE (2005)
Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics
UJF Tietge et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Pleiotropic effects of genes for insulin resistance on adiposity in baboons
G Cai et al.
OBESITY RESEARCH (2004)
Adiponectin but not resistin is associated with insulin resistance-related phenotypes in baboons
ME Tejero et al.
OBESITY RESEARCH (2004)
The baboon as a nonhuman primate model for the study of the genetics of obesity
AG Comuzzie et al.
OBESITY RESEARCH (2003)
Association of serum albumin and atherosclerosis in chronic hemodialysis patients
S Beddhu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study
JS Pankow et al.
ATHEROSCLEROSIS (2001)
A genetic linkage map of the baboon (Papio hamadryas) genome based on human microsatellite polymorphisms
J Rogers et al.
GENOMICS (2000)
Share Paper
